Understanding the Role of TAGLN2 expression in PAH

Pulmonary arterial hypertension (PAH) involves complex vascular remodeling and metabolic changes. Recent research highlights how TAGLN2 expression in PAH acts as a critical driver of the disease. By utilizing Mendelian randomization, scientists have uncovered a causal link between the Transgelin 2 (TAGLN2) gene and increased disease risk. Furthermore, they found that epigenetic factors significantly influence this pathway.

The Epigenetic Regulation of TAGLN2

DNA methylation plays a pivotal role in governing gene activity without altering the underlying sequence. Specifically, the study identified two methylation sites—cg13892570 and cg16107628—that regulate how the TAGLN2 gene is transcribed. Notably, these sites mediate the effect of TAGLN2 expression on PAH by over 86%. Consequently, this suggests that therapeutic strategies targeting DNA methylation could potentially mitigate disease progression.

Experimental Evidence and Clinical Significance

To validate these genetic findings, researchers examined lung tissues from a monocrotaline (MCT)-induced rat model. The results demonstrated that TAGLN2 mRNA was significantly upregulated in affected lung tissues. Therefore, TAGLN2 emerges as a promising biomarker for diagnosis and a potential target for personalized medicine. In addition, the study reinforces the importance of succinylation-related genes in vascular health. Clinicians may find these insights useful for understanding the molecular drivers of pulmonary vascular resistance.

FAQ on TAGLN2 and PAH

How does TAGLN2 contribute to PAH?

TAGLN2 expression in PAH promotes vascular remodeling, which increases pulmonary artery pressure. It acts as an actin-binding protein that influences the behavior of smooth muscle cells.

What is the role of DNA methylation in this process?

DNA methylation serves as an epigenetic switch that controls the transcription of the TAGLN2 gene. High levels of specific methylation can drive the overexpression of this disease-causing gene.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a substitute for professional healthcare guidance. Always consult with a qualified medical professional for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.

References

Chen Z et al. DNA Methylation-Mediated Regulation of TAGLN2 Expression Promotes Pulmonary Arterial Hypertension. Arch Med Res. 2026 May 14. doi: undefined. PMID: 42134034.

Grover V, et al. The emerging role of epigenetics in pulmonary arterial hypertension. PMC. 2015.

Archer SL, et al. Epigenetic mechanisms of pulmonary hypertension. PMC. 2012.